Jabil Inc vs Smith & Nephew plc — how do they compare? Jabil Inc trades at $365.96 (market cap $37.37B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Jabil Inc is far larger — about 3× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| JBL | SNN | |
|---|---|---|
Market Cap | $37.37B | $12.54B |
Sector | Technology | Health |
52-Week High | $385.50 | $38.70 |
52-Week Low | $192.49 | $28.73 |
Enterprise Value | $39.90B | $15.57B |
Dividend Yield | 0.09% | 2.65% |
Trailing returns across standard periods
Latest headlines on both assets
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →